Advertisement

Journal of Cancer Education

, Volume 33, Issue 2, pp 260–268 | Cite as

Awareness and Knowledge Levels of Turkish College Students about Human Papilloma Virus Infection and Vaccine Acceptance

  • Murat Oz
  • Nilufer Cetinkaya
  • Aysen Apaydin
  • Elmas Korkmaz
  • Sevda Bas
  • Emre Ozgu
  • Tayfun Gungor
Article

Abstract

Awareness of HPV by the target population is an important determinant of vaccine acceptance. The aim of this study is to evaluate the awareness of HPV infection and acceptability of the HPV vaccines among Turkish college students. College students aged 18–30 who were attending a large public university in Ankara participated in this study. The participants were asked to complete a questionnaire to elicit demographic characteristics, awareness level of HPV and HPV vaccine, and willingness to be vaccinated. One thousand one hundred sixty students responded to the invitation email and completed the questionnaire. The mean scores of female students about HPV and HPV vaccine were 7.1/15 and 3.6/9, respectively, while these scores were 7.9/15 and 3.4/9 among male students, respectively. While 51 % percent of female and 33.5 % of male students had heard of HPV and 32.8 % and 18 % of them had heard of HPV vaccine, respectively, only 1.5 % of female and 0.4 % of male students had been vaccinated against HPV. A total of 507 students (43.7 %) had previously heard of HPV. Only 309 (26.6 %) of the participants had previously heard of the HPV vaccine, and 45.1 % of the students were willing to receive HPV vaccination. The main predictors for willingness to be vaccinated were the following: sexual experience, sexual behavior, past history of sexually transmitted infection (STI), and knowledge about HPV and HPV vaccine. Higher awareness levels of HPV and HPV vaccine are significantly related to greater willingness to be vaccinated, and the main reasons for rejecting the vaccine were insufficient information about the vaccine and possible unknown side effects.

Keywords

Human papilloma virus (HPV) HPV vaccine Vaccine awareness Vaccine acceptance 

Notes

Acknowledgments

The study was approved by the Local Institutional Ethics Committee (approval number: 28.10.2014-10).

Compliance with Ethical Standards

The local Hospital’s Ethics Committee and the University’s Institutional Review Board approved this study.

Financial Disclosure

There is no financial support in the preparation of the study.

Financial Support for Authors

None.

Conflict of Interest

The authors declare that they have no conflict of interest.

References

  1. 1.
    de Sanjose S, Diaz M, Castellsague X, Clifford G, Bruni L, Munoz N et al (2007) Worldwide prevalence and genotype distribution of cervical human papillomavirus DNA in women with normal cytology: a meta-analysis. Lancet Infect Dis 7(7):453–459CrossRefPubMedGoogle Scholar
  2. 2.
    Wright TC Jr, Stoler MH, Behrens CM, Apple R, Derion T, Wright TL (2012) The ATHENA human papillomavirus study: design, methods, and baseline results. Am J Obstet Gynecol 206(1):46 e1–46e11CrossRefGoogle Scholar
  3. 3.
    Monsonego J, Cox JT, Behrens C, Sandri M, Franco EL, Yap PS et al (2015) Prevalence of high-risk human papilloma virus genotypes and associated risk of cervical precancerous lesions in a large U.S. screening population: data from the ATHENA trial. Gynecol Oncol 137(1):47–54CrossRefPubMedGoogle Scholar
  4. 4.
    Baseman JG, Koutsky LA (2005) The epidemiology of human papillomavirus infections. J Clin Virol 32(Suppl 1):S16–S24Google Scholar
  5. 5.
    Castellsague X (2008) Natural history and epidemiology of HPV infection and cervical cancer. Gynecol Oncol 110(3 Suppl 2):S4–S7CrossRefPubMedGoogle Scholar
  6. 6.
    Dunne EF, Unger ER, Sternberg M, McQuillan G, Swan DC, Patel SS et al (2007) Prevalence of HPV infection among females in the United States. JAMA 297(8):813–819CrossRefPubMedGoogle Scholar
  7. 7.
    Vardas E, Giuliano AR, Goldstone S, Palefsky JM, ED M Jr, Penny ME et al (2011) External genital human papillomavirus prevalence and associated factors among heterosexual men on 5 continents. J Infect Dis 203(1):58–65CrossRefPubMedCentralPubMedGoogle Scholar
  8. 8.
    Glick SN, Feng Q, Popov V, Koutsky LA, Golden MR (2014) High rates of incident and prevalent anal human papillomavirus infection among young men who have sex with men. J Infect Dis 209(3):369–376CrossRefPubMedGoogle Scholar
  9. 9.
    Zou H, Tabrizi SN, Grulich AE, Garland SM, Hocking JS, Bradshaw CS et al (2014) Early acquisition of anogenital human papillomavirus among teenage men who have sex with men. J Infect Dis 209(5):642–651CrossRefPubMedGoogle Scholar
  10. 10.
    Sadlier C, Rowley D, Higgins D, Sheils O, Bergin C (2014) Human papillomavirus (HPV) and the usefulness of the HPV vaccine for men who have sex with men. J Infect Dis 210(10):1679CrossRefPubMedGoogle Scholar
  11. 11.
    Dursun P, Senger SS, Arslan H, Kuscu E, Ayhan A (2009) Human papillomavirus (HPV) prevalence and types among Turkish women at a gynecology outpatient unit. BMC Infect Dis 9:191CrossRefPubMedCentralPubMedGoogle Scholar
  12. 12.
    Dursun P, Ayhan A, Mutlu L, Caglar M, Haberal A, Gungor T et al (2013) HPV types in Turkey: multicenter hospital based evaluation of 6388 patients in Turkish gynecologic oncology group centers. Turk Patoloji Derg 29(3):210–216PubMedGoogle Scholar
  13. 13.
    Guan P, Howell-Jones R, Li N, Bruni L, de Sanjose S, Franceschi S et al (2012) Human papillomavirus types in 115,789 HPV-positive women: a meta-analysis from cervical infection to cancer. International journal of cancer Journal international du cancer 131(10):2349–2359CrossRefPubMedGoogle Scholar
  14. 14.
    Dempsey AF, Abraham LM, Dalton V, Ruffin M (2009) Understanding the reasons why mothers do or do not have their adolescent daughters vaccinated against human papillomavirus. Ann Epidemiol 19(8):531–538CrossRefPubMedCentralPubMedGoogle Scholar
  15. 15.
    Klug SJ, Hukelmann M, Blettner M (2008) Knowledge about infection with human papillomavirus: a systematic review. Prev Med 46(2):87–98CrossRefPubMedGoogle Scholar
  16. 16.
    Read TR, Hocking JS, Chen MY, Donovan B, Bradshaw CS, Fairley CK (2011) The near disappearance of genital warts in young women 4 years after commencing a national human papillomavirus (HPV) vaccination programme. Sex Transm Infect 87(7):544–547CrossRefPubMedGoogle Scholar
  17. 17.
    Kim JJ, Goldie SJ (2009) Cost effectiveness analysis of including boys in a human papillomavirus vaccination programme in the United States. BMJ 339:b3884CrossRefPubMedCentralPubMedGoogle Scholar
  18. 18.
    Jit M, Brisson M, Portnoy A, Hutubessy R (2014) Cost-effectiveness of female human papillomavirus vaccination in 179 countries: a PRIME modelling study. Lancet Glob Health 2(7):e406–e414CrossRefPubMedGoogle Scholar
  19. 19.
    Patel H, Jeve YB, Sherman SM, Moss EL (2016) Knowledge of human papillomavirus and the human papillomavirus vaccine in European adolescents: a systematic review. Sex Transm Infect. doi: 10.1136/sextrans-2015-052341 Google Scholar
  20. 20.
    Kwang NB, Mahayudin T, Yien HL, Abdul Karim AK, Teik CK, Shan LP (2016) Effect of an educational intervention on knowledge of human papillomavirus vaccination among pre-university students in Malaysia. Asian Pacific journal of cancer prevention: APJCP 17(1):267–274CrossRefPubMedGoogle Scholar
  21. 21.
    Dell DL, Chen H, Ahmad F, Stewart DE (2000) Knowledge about human papillomavirus among adolescents. Obstet Gynecol 96(5 Pt 1):653–656PubMedGoogle Scholar
  22. 22.
    Stokley S, Jeyarajah J, Yankey D, Cano M, Gee J, Roark J et al (2014) Human papillomavirus vaccination coverage among adolescents, 2007-2013, and postlicensure vaccine safety monitoring, 2006-2014—United States. MMWR Morb Mortal Wkly Rep 63(29):620–624PubMedCentralPubMedGoogle Scholar
  23. 23.
    [Anonymous] (2015) Committee opinion no. 641: human papillomavirus vaccination. Obstet Gynecol, DOI:  10.1097/01.AOG.0000470103.97442.4b
  24. 24.
    Bednarczyk RA, Davis R, Ault K, Orenstein W, Omer SB (2012) Sexual activity-related outcomes after human papillomavirus vaccination of 11- to 12-year-olds. Pediatrics 130(5):798–805CrossRefPubMedGoogle Scholar
  25. 25.
    Schiller JT, Castellsague X, Garland SMA (2012) Review of clinical trials of human papillomavirus prophylactic vaccines. Vaccine 30(Suppl 5):F123–F138CrossRefPubMedCentralPubMedGoogle Scholar
  26. 26.
    Smith LM, Strumpf EC, Kaufman JS, Lofters A, Schwandt M, Levesque LE (2015) The early benefits of human papillomavirus vaccination on cervical dysplasia and anogenital warts. Pediatrics 135(5):e1131–e1140CrossRefPubMedGoogle Scholar
  27. 27.
    Marek E, Dergez T, Rebek-Nagy G, Kricskovics A, Kovacs K, Bozsa S et al (2011) Adolescents’ awareness of HPV infections and attitudes towards HPV vaccination 3 years following the introduction of the HPV vaccine in Hungary. Vaccine 29(47):8591–8598CrossRefPubMedGoogle Scholar
  28. 28.
    Forster AS, Marlow LA, Wardle J, Stephenson J, Waller J (2012) Interest in having HPV vaccination among adolescent boys in England. Vaccine 30(30):4505–4510CrossRefPubMedGoogle Scholar
  29. 29.
    Blodt S, Holmberg C, Muller-Nordhorn J, Rieckmann N (2012) Human papillomavirus awareness, knowledge and vaccine acceptance: a survey among 18-25 year old male and female vocational school students in Berlin, Germany. Eur J Pub Health 22(6):808–813CrossRefGoogle Scholar
  30. 30.
    Ratanasiripong NT, Cheng AL, Enriquez M (2013) What college women know, think, and do about human papillomavirus (HPV) and HPV vaccine. Vaccine 31(10):1370–1376CrossRefPubMedGoogle Scholar
  31. 31.
    Caskey R, Lindau ST, Alexander GC (2009) Knowledge and early adoption of the HPV vaccine among girls and young women: results of a national survey. The Journal of adolescent health: official publication of the Society for Adolescent Medicine 45(5):453–462CrossRefGoogle Scholar
  32. 32.
    Conroy K, Rosenthal SL, Zimet GD, Jin Y, Bernstein DI, Glynn S et al (2009) Human papillomavirus vaccine uptake, predictors of vaccination, and self-reported barriers to vaccination. J Women’s Health 18(10):1679–1686CrossRefGoogle Scholar
  33. 33.
    Zimet GD, Weiss TW, Rosenthal SL, Good MB, Vichnin MD (2010) Reasons for non-vaccination against HPV and future vaccination intentions among 19-26 year-old women. BMC Womens Health 10:27CrossRefPubMedCentralPubMedGoogle Scholar
  34. 34.
    Wheldon CW, Daley EM, Buhi ER, Nyitray AG, Giuliano AR (2011) Health beliefs and attitudes associated with HPV vaccine intention among young gay and bisexual men in the southeastern United States. Vaccine 29(45):8060–8065CrossRefPubMedGoogle Scholar
  35. 35.
    [Anonymous]. OECD (2015) Adult education level (indicator). doi:  10.1787/36bce3fe-en. Accessed 28 Aug 2015. In
  36. 36.
    Roberts ME, Gerrard M, Reimer R, Gibbons FX (2010) Mother-daughter communication and human papillomavirus vaccine uptake by college students. Pediatrics 125(5):982–989CrossRefPubMedGoogle Scholar
  37. 37.
    Gottvall M, Tyden T, Hoglund AT, Larsson M (2010) Knowledge of human papillomavirus among high school students can be increased by an educational intervention. Int J STD AIDS 21(8):558–562CrossRefPubMedGoogle Scholar

Copyright information

© American Association for Cancer Education 2016

Authors and Affiliations

  • Murat Oz
    • 1
  • Nilufer Cetinkaya
    • 1
  • Aysen Apaydin
    • 2
  • Elmas Korkmaz
    • 1
  • Sevda Bas
    • 1
  • Emre Ozgu
    • 1
  • Tayfun Gungor
    • 3
  1. 1.Department of Gynecological OncologyZekai Tahir Burak Women’s Health HospitalAnkaraTurkey
  2. 2.Division of StatisticsAnkara University Science FacultyAnkaraTurkey
  3. 3.Department of Gynecology and ObstetricsHitit UniversityCorumTurkey

Personalised recommendations